Skip to Main Content

Paper Details

T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.
Cell
155
2022
Author NameAffiliation
Vivek NaranbhaiMassachusetts General Hospital Cancer Center, Massachusetts General Hospital, USA Dana-Farber Cancer Institute, USA Center for the AIDS Programme of Research in South Africa
Mary CarringtonRagon Institute of MGH, Frederick National Laboratory for Cancer Research in the Laboratory of Integrative Cancer Immunology, National Cancer Institute
Mary CarringtonRagon Institute of MGH, Frederick National Laboratory for Cancer Research in the Laboratory of Integrative Cancer Immunology, National Cancer Institute
Wilfredo F Garcia-BeltranRagon Institute of MGH, Massachusetts General Hospital
Bruce D WalkerCenter for the AIDS Programme of Research in South Africa, South Africa Ragon Institute of MGH, USA The Broad Institute, USA Howard Hughes Medical Institute, USA Institute for Medical Engineering and Science, Massachusetts Institute of Technology
Bruce D WalkerCenter for the AIDS Programme of Research in South Africa, South Africa Ragon Institute of MGH, USA The Broad Institute, USA Howard Hughes Medical Institute, USA Institute for Medical Engineering and Science, Massachusetts Institute of Technology
Anthony J IafrateMassachusetts General Hospital
  • 1 - 7

Datasets